Erectile Dysfunction

Thirty-two (32) males (62%) of the patients completed the trial.

• Psychological factors can contribute to or cause erectile dysfunction.
• Levitra can be effective for ED with a psychogenic component.
• It may help break the cycle of anxiety and performance-related stress.
• Successful treatment with medication can improve self-confidence.
• It is often used in conjunction with psychological counseling or sex therapy.
• A holistic approach to ED treatment addresses both physical and mental aspects.

Retinal function was measured by ERG and FM-100 test 2, 6 and 24 hours after dosing.

• Levitra 20mg interacts with nitrates used for chest pain.
• Avoid grapefruit or grapefruit juice when taking Levitra.
• Store tablets in a cool, dry place away from children.
• Levitra does not protect against sexually transmitted diseases.
• It's essential to follow the prescribed dosage for safety.

The trial was designed to detect changes in retinal

• Bayer Levitra 20mg is a prescription medication for erectile dysfunction.
• It contains the active ingredient Vardenafil, which improves blood flow.
• Levitra 20mg should be taken about 60 minutes before intimacy.
• The medication's effects can last up to 4-5 hours.
• Do not exceed one dose within 24 hours to avoid side effects.

function that might occur in more than 10% of patients.

Aspect	Details	Notes
Storage Temperature	Between 15°C and 30°C	Keep away from heat and moisture
Keep Out of Reach of Children	Yes	To prevent accidental ingestion
Storage Conditions	Store in original packaging, away from direct sunlight	Maintain stability and potency
Expiry Date	Usually 3 years from manufacturing date	Do not use expired medication
Handling Precautions	Avoid crushing or splitting tablets	Follow prescribed instructions

Vardenafil did not produce clinically significant ERG or

Medication	Typical Dose	Onset of Action	Duration	Common Side Effects	Price Range (approx.)
Levitra (20mg)	20mg	25-60 mins	Up to 5 hrs	Headache, flushing	$$$
Viagra (Sildenafil)	50-100mg	30-60 mins	4-6 hrs	Vision changes, headaches	$$
Cialis (Tadalafil)	10-20mg	30-60 mins	Up to 36 hrs	Muscle pain, headache	$$$$
Stendra (Avanafil)	50-200mg	15-30 mins	6 hrs	Flushing, nasal congestion	$$$

FM-100 effects in healthy men compared to placebo.

Overdose/Missed Dose

The effect of 10 mg and 80 mg vardenafil on QT interval was evaluated in a single-dose, double-blind, randomized, placebo- and active-controlled (moxifloxacin 400 mg) crossover study in 59 healthy males (81% White, 12% Black, 7% Hispanic) aged 45-60 years. The QT cheapest levitra generic interval was measured at one hour post dose because this time point approximates the average time of peak vardenafil concentration. The 80 mg dose of LEVITRA (four times the highest recommended dose) was chosen because this dose yields plasma concentrations covering those observed upon co-administration of a low-dose of LEVITRA (5 mg) and 600 mg BID of ritonavir. Of the CYP3A4 inhibitors that have been studied, ritonavir causes the most significant drug-drug interaction with vardenafil. Table 1 summarizes the effect on mean uncorrected QT and mean corrected QT interval (QTc) with different methods of correction (Fridericia and a linear individual correction method) at one hour post-dose.

Patient assistance programs

No single correction method is known to be more valid than the other. In this study, the mean increase in heart rate associated with a 10 mg dose of LEVITRA compared to placebo was 5 beats/minute and with an 80 mg dose of LEVITRA the mean increase was 6 beats/minute. Therapeutic and supratherapeutic doses of vardenafil and the active control moxifloxacin produced similar increases in QTc interval. This study, however, was not designed to make direct statistical comparisons between the drug or the dose levels. The clinical impact of these QTc changes is unknown (see PRECAUTIONS).

What should I do if I accidentally take too much vardenafil?

In a separate postmarketing study of 44 healthy volunteers, single doses of 10 mg LEVITRA resulted in a placebo-subtracted mean change from baseline of QTcF (Fridericia correction) of 5 msec (90% CI: 2,8). Single doses of gatifloxacin 400mg resulted in a placebo-subtracted mean change from baseline QTcF of 4 msec (90% CI: 1,7). When LEVITRA 10mg and gatifloxacin 400 mg were co-administered, the mean QTcF change from baseline was additive when compared to either drug alone and produced a mean QTcF change of 9 msec from baseline (90% CI: 6,11). The clinical impact of these QT changes is unknown (see PRECAUTIONS, Congenital or Acquired QT Prolongation). In two independent trials that assessed 10 mg (n=41) and 20 mg (n=39) vardenafil, respectively, vardenafil did not alter the total treadmill exercise time compared to placebo. Two patients on vardenafil in the trial

Product	Dosage	Quantity + Bonus	Price
Levitra Generic	20mg	270 + 10 Pills	376.33€ 358.41€	Buy
Levitra Generic	60mg	120 + 8 Pills	372.33€ 354.60€	Buy
Levitra Generic	60mg	270 + 10 Pills	714.53€ 680.50€	Buy
Levitra Generic	10mg	360 + 10 Pills	407.94€ 388.51€	Buy
Levitra Generic	20mg	120 + 10 Pills	224.15€ 213.48€	Buy
Levitra Generic	40mg	360 + 10 Pills	704.99€ 671.42€	Buy
Levitra Generic	20mg	90 + 8 Pills	180.78€ 172.17€	Buy
Levitra Generic	40mg	120 + 8 Pills	302.37€ 287.97€	Buy
Levitra Soft Tabs	20mg	360 + 20 Pills	682.21€ 649.72€	Buy
Levitra Generic	10mg	30 + 4 Pills	62.39€ 59.42€	Buy
Levitra Generic	40mg	180 + 10 Pills	405.06€ 385.77€	Buy
Levitra Generic	10mg	20 Pills	46.54€ 44.32€	Buy
Levitra Soft Tabs	20mg	180 + 10 Pills	398.14€ 379.18€	Buy
Levitra Professional	20mg	180 + 4 Pills	502.31€ 478.39€	Buy
Levitra Generic	60mg	90 + 6 Pills	291.82€ 277.92€	Buy
Levitra Generic	10mg	180 + 10 Pills	246.74€ 234.99€	Buy

reported episodes of transient cyanopsia (objects appear blue).

¿Qué sucedería en una sobredosis?

The patient population included men aged 40-80 years with stable exercise-induced angina documented by at least one of the following: 1) prior history of MI, CABG, PTCA, or stenting (not within 6 months); 2) positive coronary angiogram showing at least 60% narrowing of the diameter of at least one major coronary artery; or 3) a positive stress echocardiogram or stress nuclear perfusion study. Results of these studies showed that LEVITRA did not alter the total treadmill exercise time compared to placebo (10 mg LEVITRA vs. placebo: 433±109 and 426±105 seconds, respectively; 20 mg LEVITRA vs. placebo: 414±114 and 411±124 seconds, respectively). The total time to angina was not altered by LEVITRA when compared to placebo (10 mg LEVITRA vs.

What should I tell my healthcare provider before taking vardenafil?

placebo: 291±123 and 292±110 seconds; 20 mg LEVITRA vs. placebo: 354±137 and 347±143 seconds, respectively). The total time to 1 mm or greater ST-segment depression was similar to placebo in both the 10 mg and the 20 mg LEVITRA groups (10 mg LEVITRA vs. placebo: 380±108 and 334±108 seconds; 20 mg LEVITRA vs. placebo: 364±101 and 366±105 seconds, respectively). LEVITRA was evaluated in four major double-blind, randomized,

Uso clínico

Vardenafil and its major circulating metabolite, M1, are highly bound to plasma proteins (about 95% for parent drug and M1). This protein binding is reversible and independent of total drug concentrations. Following a single oral dose of 20 mg vardenafil in healthy volunteers, a mean of 0.00018% of the administered dose was obtained in semen 1.5 hours after dosing. Vardenafil is metabolized predominantly by the hepatic enzyme CYP3A4, with contribution from the CYP3A5 and CYP2C isoforms. The major circulating metabolite, M1, results from desethylation at the piperazine moiety of vardenafil.

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction

The plasma concentration of M1 is approximately 26% that of the parent compound. This metabolite shows a phosphodiesterase selectivity profile similar to that of vardenafil and an in vitro inhibitory potency for PDE5 28% of that of vardenafil. Therefore, M1 accounts for approximately 7% of total pharmacologic activity. The total body clearance of vardenafil is 56 L/h, and the terminal half-life of vardenafil and its primary metabolite (M1) is approximately 4-5 hours. After oral administration, vardenafil is excreted as metabolites predominantly in the feces (approximately 91-95% of administered oral dose) and to a lesser extent in the urine (approximately 2-6% of administered oral dose).

Who should not take vardenafil?

Pediatrics: Vardenafil trials were not conducted in the pediatric population. Geriatrics: In a healthy volunteer study of elderly males (≥65 years) and younger males (18–45 years), mean Cmax and AUC were 34% and 52% higher, respectively, in the elderly males (see PRECAUTIONS, Geriatric Use and DOSAGE AND ADMINISTRATION). Consequently, a lower starting dose of LEVITRA (5 mg) in patients ≥65 years of age should be considered. Renal Insufficiency: In volunteers with mild renal impairment (CLcr = 50-80 ml/min), the pharmacokinetics of vardenafil were similar to those observed in a control group with normal renal function. In the moderate (CLcr = 30-50 ml/min) or severe (CLcr<30 ml/min) renal impairment groups, the AUC of vardenafil was 20–30% higher compared to that observed in a control group with normal renal function (CLcr>80 ml/min). placebo-controlled, fixed-dose, parallel design, multicenter trials in 2431 men

• Pre-existing cardiovascular disease is a important consideration for use.
• Physicians should consider the cardiac risk of sexual activity for each patient.
• Men with conditions like unstable angina or uncontrolled hypertension may be advised against use.
• It can cause small, temporary decreases in blood pressure.
• Patients with left ventricular outflow obstruction should use with caution.
• A medical consultation is essential to determine if Levitra is safe for you.

aged 20-83 (mean age 57 years; 78% White, 7% Black, 2% Asian, 3% Hispanic and 10% Other/Unknown).

Where to participate

Vardenafil pharmacokinetics have not been evaluated in patients requiring renal dialysis (see PRECAUTIONS, Renal Insufficiency, and DOSAGE AND ADMINISTRATION). Hepatic Insufficiency: In volunteers with mild hepatic impairment (Child-Pugh A), the Cmax and AUC following a 10 mg vardenafil dose were increased by 22% and 17%, respectively, compared to healthy control subjects. In volunteers with moderate hepatic impairment (Child-Pugh B), the Cmax and AUC following a 10 mg vardenafil dose were increased by 130% and 160%, respectively, compared to healthy control subjects. Consequently, a starting dose of 5 mg is recommended for patients with moderate hepatic impairment, and the maximum dose should not exceed 10 mg (see PRECAUTIONS and DOSAGE AND ADMINISTRATION). Vardenafil has not been evaluated in patients with severe (Child-Pugh C) hepatic impairment.

What are the most common side effects of vardenafil?

In a clinical pharmacology study of patients with erectile dysfunction, single doses of vardenafil 20 mg caused a mean maximum decrease in supine blood pressure of 7 mmHg systolic and 8 mmHg diastolic (compared to placebo), accompanied by a mean maximum increase of heart rate of 4 beats per minute. The maximum decrease in blood pressure occurred between 1 and 4 hours after dosing. Following multiple dosing for 31 days, similar blood pressure responses were observed on Day 31 as on Day 1. Vardenafil may add to the blood pressure lowering effects of antihypertensive agents (see PRECAUTIONS, Drug Interactions). A study was conducted in which the blood pressure and heart rate response to 0.4 mg nitroglycerin (NTG) sublingually was evaluated in 18 healthy subjects following pretreatment with LEVITRA 20 mg at various times before NTG administration.

Sustained efficacy and tolerability of vardenafil (Levitra®), a highly potent, selective phosphodiesterase-5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial

LEVITRA 20 mg caused an additional time-related reduction in blood pressure and increase in heart rate in association with NTG administration. The blood pressure effects were observed when LEVITRA 20 mg was dosed 1 or 4 hours before NTG and the heart rate effects were observed when 20 mg was dosed 1, 4, or 8 hours before NTG. Additional blood pressure and heart rate changes were not detected when LEVITRA 20 mg was dosed 24 hours before NTG. Figure 2: Placebo-subtracted point estimates (with 90% CI) of mean maximal blood pressure and heart rate effects of pre-dosing with LEVITRA 20 mg at 24, 8, 4, and 1 hour before 0.4 mg NTG sublingually. Because the disease state of patients requiring nitrate therapy is anticipated to increase the likelihood of hypotension, the use of vardenafil by patients on nitrate therapy or on nitric oxide donors is contraindicated (see CONTRAINDICATIONS). The doses of LEVITRA in these studies were 5 mg, 10 mg, and 20 mg.

Aspect	Details	Notes
Legal Status	Prescription-only medication	Requires a doctor’s prescription
Availability	Widely available in pharmacies globally	Also accessible via online pharmacies
Prescription Requirements	Medical evaluation needed before purchase	Ensures safe and proper use
Generic Versions	Available in some markets	May be less expensive
Regulatory Agencies	Approved by FDA (USA), EMA (Europe), other national agencies	Ensures safety and efficacy standards

Two of these trials were conducted in the general ED population and two in special ED populations (one in patients with diabetes mellitus and one in post-prostatectomy patients).

Key Participants Requirements

Single oral doses of phosphodiesterase inhibitors have demonstrated transient dose-related impairment of color discrimination (blue/green) using the Farnsworth-Munsell 100-hue test and reductions in electroretinogram (ERG) b-wave amplitudes, with peak effects near the time of peak plasma levels. These findings are consistent with the inhibition of PDE6 in rods and cones, which is involved in phototransduction in the retina. The findings were most evident one hour after administration, diminishing but still present 6 hours after administration. In a single dose study in 25 normal males, LEVITRA 40 mg, twice the maximum daily recommended dose, did not alter visual acuity, intraocular pressure, fundoscopic and slit lamp findings. In another double-blind, placebo controlled clinical trial, at least 15 doses of 20 mg vardenafil were administered over 8 weeks versus placebo to 52 males.